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Abstract
Pharyngeal aspiration of single walled carbon nanotubes (SWCNT) caused inflammation,
pulmonary damage and an altered cytokine network in the lung. Local inflammatory response in
vivo was accompanied by modified systemic immunity as documented by decreased proliferation
of splenic T cells. Pre-incubation of naïve T cells in vitro with SWCNT-treated dendritic cells
reduced proliferation of T cells. Our data suggest that in vivo exposure to SWCNT modify
systemic immunity by modulating dendritic cell function.
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Carbonaceous nanoparticles and their derivatives have been widely used for a number of
applications, including energy storage devices, super-conducting products, magnets,
biologic materials and catalysts. Numerous studies have focused on toxicity issues
associated with nanoparticle (NP) exposure. However, very limited information is currently
available regarding their immunomodulating potential. The early phase of lung innate
immune response to many pathogens is characterized by onset of inflammation mediated by
phagocytic cells, i.e., polymorphonuclear leukocytes (PMNs), alveolar macrophages (AM),
and antigen presenting dendritic cells (DC) populating the lungs. The latter are mobilized
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and recruited into inflammation sites where they serve their primary duty – antigen
recognition, capture and subsequent presentation.1 Stimulation of T cells by DC is crucial
for adaptive immune responses. The nature of encountered antigen(s) as well as
environmental signals during antigen uptake by DC shape the subsequent T cell response.
The inflammatory milieu in the lung following NP exposure provides a range of signals
required for activation and potential polarization of local DC subsets. These signals are
presented in the context of cytokines and chemokines, damaged cells/cell fragments, and,
perhaps, specific features of the NP itself. However, as of now, it is not yet clear if the
exposure of DC to NP affects DC maturation/function. NP given to the lung along with
antigens displayed adjuvant properties and enhanced respiratory and systemic allergic
responses.2–5 Nevertheless, detailed mechanisms of these adjuvant effects have not been
disclosed. Noteworthy, pristine SWCNT, in contrast to carboxylated or coated SWCNT, do
not carry charges on their surface and are poorly recognized by DC.6 It has been reported
that some carbonaceous particles, e.g., carbon black or diesel exhaust particles, may
stimulate functional activity of DC in vitro.7–9 Recently, it has been shown that exposure of
mice to respirable multi-walled carbon nanotubes (MWCNT) did not elicit pulmonary
inflammation yet caused suppression of T cell proliferation.10,11
In the current study, we evaluated site-specific pulmonary inflammation and systemic
immune response in mice after the pharyngeal aspiration of SWCNT. Here we present
evidence that the mechanisms of altered systemic immunity found in SWCNT-exposed mice
may be, to some extent, due to direct effects of SWCNT on DC.
RESULTS
Characterization of SWCNT employed in the study
SWCNT (CNI, Houston, TX) produced by the high-pressure CO disproportionation (HiPco)
process, employing CO in a continuous-flow gas phase as the carbon feedstock and Fe(CO)5
as the iron-containing catalyst precursor and purified by acid treatment to remove metal
contaminates were used in the study. Analysis performed by NMAM 5040 and ICP-AES
revealed that SWCNT comprises 99.7% (wt) elemental carbon and 0.23% (wt) iron. For
purity assessment of HiPco SWCNT, we used several standard analytical techniques,
including thermo-gravimetric analysis with differential scanning colorimetry (TGA-DSC),
thermo-programming oxidation (TPO), and Raman and near-infrared (NIR) spectroscopy.
Comparative analytical data obtained by TGA-DSC, TPO, NIR, and Raman spectroscopy
revealed that >99% of carbon content in the SWCNT HiPco product was accountable in a
carbon nanotube morphology. Morphology of SWCNT is presented at Figure 1(A,B). The
length of the individual SWCNT is approximately 1–3 μm as confirmed by transmission
electron microscopy (TEM). Surface area was determined by Brunauer, Emmett, and Teller
analysis. Zeta potential and particle size were determined on the Malvern Zetasizer Nano
(Malvern Instruments, Westborough, MA). Zeta potential was measured at −42.3 ± 0.9 mV.
The mean diameter and surface area of SWCNT were 1–4 nm and 1040 m2/g, respectively.
Stock suspensions (1 mg/ml) were prepared before each experiment in PBS or culture
medium, pH was adjusted to 7.0. To obtain a more homogenous and dispersed suspension,
SWCNT were ultrasonicated (30 sec × 3 cycles). The dispersity of sonicated SWCNT
assessed as previously described12 was 83%.
Cell counts in the lungs of mice exposed to SWCNT
The degree of inflammatory response induced by the aspirated particles was estimated by
the number of total cells, macrophages, PMNs, and lymphocytes recruited into the mouse
lungs and recovered in the broncho-alveolar lavage (BAL) fluid. Experiments were
conducted under a protocol approved by the Animal Care and Use Committee of NIOSH.
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SWCNT were administered by pharyngeal aspiration (40 or 120 μg/mouse). At days 1 and 7
post exposure, mice were weighed, sacrificed and BAL fluid was collected in sterile
centrifuge tubes. Cell counts were performed with an electronic cell counter. AM, PMNs
and lymphocytes were identified by their typical cell shape and morphology in the cytospin
preparations stained with a Hema-3 kit (Fisher Scientific, Pittsburgh, PA). Pulmonary DC
were analyzed in non-lavaged lungs by flow cytometry. DC counts were normalized by the
total numbers of lung cells upon digestion. Pulmonary exposure to SWCNT significantly
increased the number of PMNs in BAL fluid on day 1 post exposure, with an almost 500-
fold increase at the high dose of SWCNT, and up to a 37-fold increase in response to the
lower dose as compared to controls (Figure 2B). On day 7 post exposure, PMNs, although
markedly decreased as compared to day 1 post exposure, still remained at the elevated levels
up to 22-fold and 6-fold over controls at the two respective doses (p<0.05). AM displayed a
different homing pattern with significant increases observed only after day 7 post exposure
(Figure 2A). Lymphocyte recruitment into the lung was not detected on day 1 post exposure.
A relatively small number of lymphocytes were found later on day 7 post exposure in BAL
fluid (p<0.05) (Figure 2C). Notably, elevated numbers of DC were found in the lung at 1d
and 7d post exposure (p<0.05) (Figure 2D).
Pulmonary exposure to SWCNT suppresses T cell responsiveness in the spleen of mice
To investigate if pulmonary exposure to SWCNT (in the absence of specific antigen) altered
systemic immunity, we tested the proliferative response of splenic T cells stimulated with
Concavalin A. In SWCNT-exposed animals we observed the dose-dependent decrease of
splenocyte proliferation, as evidenced by decrease of both proliferation and expansion
indices (Figure 3). The proliferation index was decreased at all doses of SWCNT, reaching
its maximum (~15% decrease) at 120 μg/mouse dose while the expansion index showed
~23% decrease at that dose, as compared to control.
Suppressed systemic immunity in SWCNT-exposed mice is associated with
the direct effects of SWCNT on DC—To assess if DC could be responsible for
modulation of systemic immunity in SWCNT-treated mice, we evaluated the ability of
SWCNT-exposed DC to alter T cell responses in vitro. Internalization of SWCNT by DC
was observed at 48h of exposure, as evidenced by transmission electron microscopy (Figure
4).
We found that SWCNT-exposed DC are able to modulate T cell response in vitro. Notably,
co-culturing of T cells with SWCNT- exposed DC was shown to suppress the T cell
proliferation response upon re-stimulation with freshly generated, unexposed DC (Figure 5).
T cells that have been pre-incubated with SWCNT-exposed DC, had a proliferation indices
of 1.6±0.07 or 1.4±0.01 (for DC exposed to 6.25 or 25 μg/ml SWCNT, respectively) as
compared to 1.8±0.01 in controls (p<0.05). Pre-incubation of T cells with LPS-exposed DC
(1.0 μg/ml) used as a positive control, resulted in increase of T cell proliferation (2.3±0.03,
p<0.05). Simultaneous treatment of DC with LPS (1.0 μg/ml) and SWCNT (25N μg/ml) was
found to eliminate LPS-induced DC activation and subsequent T cell proliferation
(1.8±0.2%) (Figure 5A). Expansion index, reflecting the expansion of the whole culture
showed the same pattern as the proliferation index (Figure 5B). We found that SWCNT-
exposed DC suppress T cell responses to antigenic stimuli, thus suggesting that the direct
effects of SWCNT on DC may cause immune suppression observed in vivo.
Exposure to SWCNT does not alter DC phenotype—To investigate if DC-
suppressed T cell responsiveness was due to altered DC phenotype, we evaluated expression
of maturation markers/co-stimulatory molecules and MHC class II on DC exposed to
SWCNT. We did not observe any significant changes in the expression of CD80, CD86,
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CD40 or MHC class II molecules by DC after 48h of exposure (6.25 or 25 μg/ml) of
SWCNT (Table 1). Treatment of DC with E. coli LPS, a positive control, induced
phenotypical maturation of DC (increased expression of CD80, CD86, CD40, MHCII
molecules). Noteworthy, DC exposed to both LPS and SWCNT (25 μg/ml) had the
phenotype indistinctive from LPS-only exposed DC, suggesting that SWCNT do not affect
LPS-induced DC maturation. Therefore, other mechanism(s), beyond DC phenotypical
alterations, might be involved in suppression of T cells by SWCNT-exposed DC.
DISCUSSION
Results from several laboratories have demonstrated SWCNT-driven robust inflammation,
granulomatous lesions and interstitial fibrosis in the lungs of exposed animals.13–17
Complex interactions between the pathophysiologic mechanisms—inflammatory response
and oxidative stress, that can synergistically amplify each other and cause enhanced
pulmonary toxicity - have been revealed.18 In several recent field studies airborne
concentration of nanotubes was reported as high as 53 μg/m3/SWCNT or 430 μg/m3/
MWCNT.19,20 Thus, under manufacturing settings, lung burdens comparable to used in our
study (adjusted by lung surface area) can be achieved by workers in 2.3–19.3 years (53–430
μg/m3, lung ventilation of 9.6 m3/day,21 deposited pulmonary fraction of 10%22). Lifetime
human lung burdens at these nanotube concentrations in the air (53 or N430μg/m3) will be
0.57 g or 4.54 g, respectively. This will bring us to assessed exposure levels in rodents that
are equivalents to 0.28 or 2.23 mg/mouse. In the current study, a bolus SWCNT delivery
protocol, pharyngeal aspiration, was used to expose mice. This technique provides
widespread delivery of particles throughout the lung at a single time point.23,24 It has been
demonstrated that at comparable particle burdens pulmonary responses to bolus instillation
reflected the pulmonary response to inhalation.25,26 There is compelling evidence that
poorly soluble carbonaceous nanoparticles e.g. nanotubes are not appreciably cleared from
the lungs following intratracheal instillation or inhalation.27,28 Therefore, the doses of
SWCNT utilized in the current study (40–120 μg/mouse) are relevant to the actual
workplace and certainly less than those that could be achieved during life-time work
exposures (8hr/d, 5 d/wk, 45 yrs).29
Our data are in line with these previous reports confirming that SWCNT are capable of
inducing pulmonary inflammation. In fact, we observed a dose dependent increase in cell
counts including macrophages and PMNs in BAL fluid after the animals exposure to
SWCNT. Notably, SWCNT-induced inflammation facilitated the recruitment of DC to the
lung tissues (Figure 2D), increasing chances of direct DC/SWCNT interactions. The acute
phase of lung inflammation (on day 1 post exposure) was characterized by an increase of
both pro-inflammatory cytokines (TNF-α, IL-6) as well as chemotactic factors (MCP1). Our
assessment of pulmonary damage, measured by LDH and protein release in the BAL fluid,
correlates well with the observed pulmonary inflammation (see suppl., Figures S1, S2).
Altogether, SWCNT-induced inflammation favors the recruitment of immune cells to the
lung and provides additional signals for APC activation and maturation in the context of
“danger signals” and a specific cytokine/chemokine environment.30
In vivo, SWCNT induced a pro-inflammatory milieu in the lungs that could lead to T cell
activation and systemic immunostimulation. However, our data suggest that in SWCNT-
exposed animals splenic T cell responses were suppressed (Figure 3).
Several lines of evidence indicate that local inflammation following SWCNT exposure is
able to modify immune responses. Recent in vivo studies revealed the adjuvant effects of
various NP administered along with a specific antigen/allergen. Increased serum levels of
ovalbumin (OVA)-specific IgE, as well as elevated eosinophil counts in BAL following
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MWCNT or SWCNT + OVA exposure were reported.2,5,31 As for the response to infectious
agents, it has been demonstrated that SWCNT and diesel exhaust particles (DEP) exposure
increased the severity of Listeria monocytogenes infection in vivo.32,33 Pulmonary exposure
to MWCNT caused suppressed responses of spleen cells to mitogen stimulation, as reported
by Mitchell et al.10,11 In these studies, no significant pulmonary inflammation was
documented. However, TGF-β release from the lung was proposed to be the mechanism of T
cell dysfunction and impaired systemic immunity. Here we provide evidence that DC might
be involved in translation of immune suppressive signal(s) from the inflamed lung to
peripheral lymphoid tissues modulating systemic immunity.
DC are the major bridge between the innate and adaptive immune responses. DC are APC,
that are highly efficient in antigen presentation and stimulation of T lymphocytes.34 DC
take-up and process antigens, migrate from peripheral tissues to lymphoid organs, present
antigens, produce cytokines and express co-stimulatory molecules critical for efficient
activation of T cells required for the development of adaptive immune responses. DC exist
in two functionally and phenotypically distinct states, immature and mature. Immature DC
are widely distributed throughout the body and occupy sentinel positions in many non-
lymphoid tissues including the lung. They constantly test their environment for antigens by
phagocytosis, macropinocytosis, and pinocytosis.35 Immature DC express relatively low
levels of MHC class I, class II, and co-stimulatory molecules.36 After engulfing antigens and
activation by proinflammatory cytokines and other signals (like bacterial LPS), immature
DC differentiate into mature cells. Mature DC have a reduced potential for antigen uptake
but a high capacity for antigen presentation and T cell stimulation.37,38 Notably, it was
previously reported that a fraction of DC may translocate from the lung to the spleen.39
While it is unlikely that SWCNT are recognized as full antigens by APC, it is plausible that
SWCNT share some similarities with bacterial/viral components and are capable of
triggering pattern recognition receptors on DC thus promoting DC maturation and
migration. It was previously reported9 that exposure of DC to carbon black stimulated DC
maturation and T cell proliferation in vitro. A [Gd@C(82)(OH)(22)](n) fullerene derivative
was also reported to induce maturation of DC and stimulate cytokine production by DC,
including IL-12p70.40 In the report by Inoue et al.,5 SWCNT have been shown to increase
the number of CD86+ cells in bone marrow-derived DC culture at 5 and 10 μg/ml doses.
However, in that study in DC-T cell co-cultures, OVA-specific T cell proliferation was
decreased at these SWCNT doses. In our study, the expression of CD80, CD86, CD40 or
MHC class II molecules was not changed on DC following 48h SWCNT exposure in vitro.
It appears that SWCNT do not provide sufficient signals to activate DC in vitro. Current
findings are supported by data of Palomaki et al., who also did not observe significant
effects of MWCNT or SWCNT on maturation of cultured DC in vitro.41
In our study, exposure of DC to E. coli LPS induced phenotypical maturation of DC (Table
1). When LPS-exposed DC were mixed with T cells we observed facilitated T cell
proliferation (Figure 5). Administration of LPS + SWCNT to DC did not change LPS-
induced DC phenotypical maturation (Table 1). Indeed, when T cells were mixed with LPS
+SWCNT treated DC we observed decreased proliferation (Figure 5). Combined, these
findings suggest that SWCNT do not interfere with recognition of LPS by DC. We can
speculate that SWCNT exposure may intervene with antigen capture/processing and/or
presentation, thereby leading to compromised DC/T cell interactions. Recently, it has been
shown that SWCNTs may interfere with the cytoskeleton actin, in the absence of acute
cytotoxicity.42 In this context, our previous studies have shown that SWCNT are not acutely
cytotoxic to primary human macrophages but exposure to SWCNT resulted in marked
suppression of the ability of macrophages to ingest apoptotic cells, a process that relies
heavily on reorganization of the actin cytoskeleton.43,44 Such effects could have a negative
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impact on the ability of DCs to stimulate T cell proliferation. Moreover, as has been
published earlier, DC could suppress T cells via expression of B7-H1/PD-1 and CTLA-4
molecules.45 Previous reports have also implicated the induction of indoleamine 2,3-
dioxygenase (IDO), IL-10, arginase, NO, SOCS, Foxo3 in mechanisms by which antigen-
presenting cells may regulate T-cell responses.46–51 In our preliminary experiments, we
have not seen changes in IL-10 release in DC/T cells co-cultures (data not shown).
Identification of potential mechanisms of T cell suppression by SWCNT-exposed DC is a
subject of our further studies.
The immune suppression observed in the current study may have significant biological
relevance as a defense mechanism against unnecessary and potentially harmful cytotoxic or
antibody-mediated immune responses to a “harmless”, non-proliferating pathogen –
SWCNT. The T cell suppression and early granuloma formation13 concomitantly lessen the
acute phase of inflammation. Involvement of DC in SWCNT-induced granulomatous lesions
and fibrosis warrants further investigations. Interestingly, according to our preliminary data,
the T cell suppression was sustained 2 weeks after exposure to SWCNT (not shown).
Obviously, the safe immunological outcome of an exposure to a “harmless pathogen” would
be a tolerogenic adaptive response. However, one cannot exclude a possible role of
surfactant lipid and protein components that can strongly adhere to the SWCNT surface, and
hence completely change their recognition profile by DC resulting in a different processing
and subsequent antigen presentation to T cells. For example, we recently demonstrated that
coating of SWCNT with anionic phospholipids - phosphatidylserine and
diacylphophatidylglycerol - may markedly stimulate recognition and uptake of SWCNT by
professional phagocytes, including DC.6 This may in turn affect functional responses i.e.
antigen processing and T cell presentation. Moreover, our recent studies have indicated that
coating of SWCNT with components of lung surfactant impacts the ability of phagocytes to
internalize SWCNT (Kagan et al., unpublished data). Thus, the nanoparticle-modified self-
or foreign proteins can be adversely recognized by APC leading to the breakage of normal
self-tolerance and the development of autoimmune or allergic responses.
In conclusion, suppressed immune responsiveness following pulmonary exposure to
SWCNT is likely to augment host susceptibility to infections and may also facilitate tumor
progression. The detailed mechanisms by which SWCNT-exposed DC suppress T cell
proliferation require further investigations.
METHODS
Animals
Specific pathogen–free adult female BALB/c and C57BL/6 mice (7–8 wk old) were
supplied by Jackson Labs (Bar Harbor, ME). Animals were individually housed in the
National Institute for Occupational Safety and Health (NIOSH) facilities approved by the
Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).
Mice were acclimated for 1 wk before use. Sterile Beta Chip bedding (Northeastern
Products, Warrensburg, NY) was changed weekly. Animals were supplied with tap water
and food (Harlan Teklad, 7913, Harlan Teklad, Madison, WI) ad libitum and housed under
controlled light, temperature, and humidity conditions. Experiments were conducted under a
protocol approved by the Animal Care and Use Committee of NIOSH.
Animal exposure – pharyngeal aspiration
Pharyngeal aspiration was used to introduce SWCNT to the mouse (BALB/c) lung. In brief,
after anesthesia with a mixture of ketamine and xylazine (Phoenix, St. Joseph, MO) (62.5
and 2.5 mg/kg subcutaneous in the abdominal area), the mouse was placed on a board in a
Tkach et al. Page 6













near-vertical position, and the tongue was gently extended with lined forceps. A suspension
of SWCNT (40, 80 or 120 μg/mouse; 60 μl in PBS) was placed posterior in the throat, and
the tongue was held until the suspension was aspirated into the lungs. Five or six animals per
study group were used. Particles were sterilized before administration by autoclaving the
particle suspension.
Bronchoalveolar lavage
At days 1 and 7 post exposure, mice were weighed and anesthetized with intraperitoneal
injection of sodium phenobarbital and exsanguinated. The trachea was cannulated with a
blunted 22-gauge needle, and bronchoalveolar lavage (BAL) was performed with cold
sterile Ca2+ and Mg 2+-free PBS at a volume of 0.7 ml for first lavage (kept separate) and
0.8 ml for subsequent lavages. Approximately 5 ml of BAL fluid per mouse were collected
and pooled in sterile centrifuge tubes. Pooled BAL cells were washed in Ca2+ and Mg2+-free
PBS by alternate centrifugation (800 × g for 10 min at 4°C) and resuspension. Cell-free first-
fraction BAL aliquots were frozen and kept until processed.
BAL cell counting and differentials
The degree of inflammatory response induced by the aspirated particles was estimated by
the total cells, macrophages, PMNs, and lymphocytes recruited into the mouse lungs and
recovered in the BAL fluid. Cell counts were performed with an electronic cell counter
equipped with a cell sizing attachment (Coulter model Multisizer II with a 256C
channelizer; Coulter Electronics, Hialeah, FL). Alveolar macrophages, neutrophils, and
lymphocytes were identified by their characteristic cell shape in cytospin preparations
stained with a Hema-3 kit (Fisher Scientific, Pittsburgh, PA), and differential counts of BAL
cells were performed. Three hundred cells per slide were counted.
Pulmonary DC counts
For pulmonary DC analysis, non-lavaged lungs were dispersed using 2% collagenase A and
0.75% DNAse I in RPMI 1640 with 10% FBS at 37°C for 1h and labeled with anti-CD11b
and anti-CD11c antibodies (BD Biosciences, CA) directly conjugated to FITC or PE.
Percent of CD11c+/CD11b+ cells was obtained by flow cytometry. DC counts were
normalized by total cell numbers in the digested lung.
Spleen harvest and cell isolation
Spleens from exposed or non-exposed BALB/c mice (day 7 post exposure) were aseptically
harvested into 5 ml of sterile supplemented medium in a sterile culture dish. Harvested
spleens were ground and suspension filtered through a cell strainer. Isolated splenocytes
were centrifuged at 300 g for 10 min. Red blood cells were lysed with lysing buffer (155
mM NH4Cl in 10 mM Tris-HCl buffer (pH 7.5), 25°C) for 3 min. After lysis, splenocytes
were washed with complete RPMI 1640 medium supplemented with 2 mM L-glutamine,
100 U/ml penicillin, 100 [g/ml streptomycin, 10 mM HEPES, 10% heat-inactivated FBS, 0.1
mM nonessential amino acids, and 1 mM sodium pyruvate (Invitrogen Life Technologies)
(further referred as complete medium) and pellets were resuspended in 4 ml of complete
medium. T cells (utilized in MLR assay) were obtained from spleen cell suspensions by
passage through the nylon wool columns, counted using hemacytometer, diluted in the
complete medium and used immediately for subsequent assays.
DC generation
Murine DC were generated from hematopoietic progenitors isolated from bone marrow.
Bone marrow cells were collected from tibias and femurs of C57BL/6 mice, passed through
a nylon cell strainer to remove debris. Bone marrow cells were then depleted of red blood
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cells with lysing buffer for 3 min. The single-cell suspensions were then incubated with anti-
mouse B220, CD4 and CD8 antibodies for 1 h at 4 °C followed by incubation with guinea
pig complement for 30 min at 37 °C to deplete B and T lymphocytes. Cells were then
cultured overnight (37°C, 5% CO2) in six-well plates (Falcon) at the concentration of 1 ×
106 cells/ml in complete medium. The nonadherent cells were collected and seeded at a
concentration of 2 × 105 cells/ml in six-well plates in complete medium in the presence of
recombinant mouse GM-CSF (1000 U/ml) and IL-4 (1000 U/ml) (PeproTech, Rocky Hill,
NJ).
Splenocyte proliferation, ex-vivo
Splenocytes were obtained from exposed (40, 80 or 120 μg/mouse) or non-exposed BALB/c
mice (day 7 post exposure). Cells were labeled with 5-(and-6)-carboxyfluorescein diacetate
(CFSE) at 5μM concentration for 5 min (Invitrogen, Carlsbad, CA), counted using a
hemacytometer, diluted in complete medium (1×106 cells/ml) and stimulated with 5 μg/ml
Concavalin A (Sigma, St. Louis, MO) for 4 days in 24 well plates in triplicates. The
proliferation response was measured using flow cytometry (BD FACSCalibur instrument,
BD, NJ). Dead cells were excluded from the assay with propidium iodide staining preceding
the flow cytometry. The background fluorescence readings were subtracted during the
analysis. Proliferation index is the average number of cell divisions that the responding T
cells underwent. Only responding T cells are reflected in the proliferation index. Expansion
index determines the fold-expansion of the overall culture. This statistic is identical to that
obtained by manual cell counting, and is predicted to be closely related to a 3H-T assay of
the culture (http://www.flowjo.com/v9/html/proliferation.html). The proliferation and
expansion indices were calculated from flow cytometry data using Flowjo software package
(Tree Star Inc, Ashland, OR).
Mixed leukocyte reaction (MLR)
Cultured bone marrow-derived (C57BL/6 mice) DC were exposed to SWCNT (6.25 or 25
μg/ml), E. coli LPS (1 μg/ml, Sigma, St. Louis, MO), both (1 μg/ml LPS + 25 μg/ml
SWCNT), or vehicle only for 48h on day 5 of DC culture. Non-cytotoxic doses of SWCNT
were selected in the preliminary experiments (>95% viability after 48h exposure as
determined by trypan blue exclusion). Sterile diluted suspensions of SWCNT in complete
medium were sonicated and added to the cells (8 × 105) to reach final concentrations of 6.25
or 25 [g/ml. The content of the wells was gently mixed and cultured for additional 48h. At
day 7, exposed DC were collected, washed twice in complete medium, counted and
aliquoted. Unexposed mouse (BALB/c) T lymphocytes were used as responder cells in
MLR. MLR was set at a 1:30 DC:T cell ratio (after preliminary optimization). Following
72h of co-culture, exposed DC 16 (CD11c positive cells) were depleted utilizing magnetic
separation. Co-cultured cells were collected, labeled with CD11c MicroBeads
(MiltenyiBiotec GmbH, Germany) according to the manufacturer’s protocol and passed
through LD columns mounted on a MidiMACS separator (MiltenyiBiotec GmbH,
Germany). The effluent T cells were collected and labeled with 5-(and-6)-
carboxyfluorescein diacetate (CFSE) at 5μM concentration for 5 min (Invitrogen, Carlsbad,
CA). The labeled DC-depleted T cells were mixed with newly generated unexposed
allogeneic DC (day 7 of DC culture) at a 1:30 DC:T cell ratio. The T cell proliferation
response was measured on day 5 of MLR using flow cytometry (BD FACSCalibur
instrument, BD, NJ). The proliferation and expansion indices were calculated from flow
cytometry data using Flowjo software package (Tree Star Inc, Ashland, OR).
DC phenotype
To determine DC phenotype, cells were exposed for 48h to SWCNT, washed in FACS
medium (Hanks Balanced Salt Solution containing 0.1% BSA and 0.1% NaN3) and stained
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with appropriately diluted antibodies (BD Biosciences, CA) directly conjugated with FITC
or PE, followed by fixation in 2% paraformaldehyde. Control samples were labeled with
isotype-matched antibodies conjugated with the same fluorochrome. Expression of CD11c,
CD80, CD86, CD40 and MHCII (IAB) was measured using the BD FACS Calibur
instrument.
Statistical analysis
Results were compared by one-way ANOVA and Student’s unpaired t test with Welch’s
correction for unequal variances. All results are presented as means ± SEM. P values of <
0.05 were considered to be statistically significant.
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Transmission (A) and scanning (B) electron microscopic images of SWCNT.
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Inflammatory response in the lung of mice after pharyngeal aspiration of SWCNT. Open
bars – 1 day post exposure; closed bars – 7 days post exposure. Data are shown as means ±
SEM (3 experiments, 6 animals/group); *p<0.05 vs. α p<0.05 vs. 40 μg/mouse SWCNT
exposure, βp<0.05 vs. 1d post exposure.
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Suppressed splenic T cell proliferation following pharyngeal aspiration of SWCNT. A –
Proliferation index. B – Expansion index. C – Representative cell division profile from
control animal. D - Representative cell division profile from SWCNT-exposed animal (120
μg/mouse). Data are shown as means ± SEM (2 experiments, 5 animals/group); *p<0.05 vs.
control.
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A typical TE micrograph illustrating internalization of SWCNT (arrow) by DC (in vitro) at
48h of exposure.
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Co-culturing of T cells with SWCNT exposed DC suppresses the T cell proliferation
response. A – Proliferation Index. B – Expansion Index. T cells were incubated for 48h with
SWCNT-exposed DC, LPS-exposed DC, or LPS+SWCNT exposed DC. Following co-
incubation, exposed DC were depleted and freshly generated DC were added as stimulatory
cells. Responder T cell proliferation was measured in 48h. T cells co-incubated with
SWCNT-exposed DC showed impaired proliferation. T cells co-incubated with LPS-
exposed DC showed increased proliferation. Proliferation of T cells co-incubated with LPS
+SWCNT-treated DC was decreased to the control levels. In other words, exposure to
SWCNT abrogated the stimulatory effect of LPS on DC. Data are shown as means ± SEM
(3 experiments); *p<0.05 vs. control, αp<0.05 vs. LPS exposure, βp<0.05 vs. 25 μg/ml
SWCNT exposure.
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